These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma. Marcelin AG; Gorin I; Morand P; Ait-Arkoub Z; Deleuze J; Morini JP; Calvez V; Dupin N AIDS Res Hum Retroviruses; 2004 Jul; 20(7):704-8. PubMed ID: 15307914 [TBL] [Abstract][Full Text] [Related]
23. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus. Engels EA; Pittaluga S; Whitby D; Rabkin C; Aoki Y; Jaffe ES; Goedert JJ Mod Pathol; 2003 May; 16(5):424-9. PubMed ID: 12748248 [TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma. Stebbing J; Sanitt A; Teague A; Powles T; Nelson M; Gazzard B; Bower M J Clin Oncol; 2007 Jun; 25(16):2230-5. PubMed ID: 17470847 [TBL] [Abstract][Full Text] [Related]
25. Kaposi's-sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals. Rizzieri DA; Liu J; Miralles D; Traweek ST Cancer J Sci Am; 1997; 3(3):153-6. PubMed ID: 9161780 [TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Cesarman E; Knowles DM Semin Diagn Pathol; 1997 Feb; 14(1):54-66. PubMed ID: 9044510 [TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi's sarcoma lesions. Pak F; Mwakigonja AR; Kokhaei P; Hosseinzadeh N; Pyakurel P; Kaaya E; Bogdanovic G; Selivanova G; Biberfeld P Eur J Cancer; 2007 Aug; 43(12):1877-82. PubMed ID: 17627810 [TBL] [Abstract][Full Text] [Related]
29. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma. Krown SE J Clin Oncol; 2004 Feb; 22(3):399-402. PubMed ID: 14752065 [No Abstract] [Full Text] [Related]
30. [Kaposi's sarcoma]. Imamura A Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094 [TBL] [Abstract][Full Text] [Related]
31. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team. Noy A; Scadden DT; Lee J; Dezube BJ; Aboulafia D; Tulpule A; Walmsley S; Gill P J Clin Oncol; 2005 Feb; 23(5):990-8. PubMed ID: 15598977 [TBL] [Abstract][Full Text] [Related]
32. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021 [TBL] [Abstract][Full Text] [Related]
34. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy. Stebbing J; Sanitt A; Nelson M; Powles T; Gazzard B; Bower M Lancet; 2006 May; 367(9521):1495-502. PubMed ID: 16679162 [TBL] [Abstract][Full Text] [Related]
35. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study. Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM; AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658 [TBL] [Abstract][Full Text] [Related]
36. Management of AIDS-related Kaposi's sarcoma. Di Lorenzo G; Konstantinopoulos PA; Pantanowitz L; Di Trolio R; De Placido S; Dezube BJ Lancet Oncol; 2007 Feb; 8(2):167-76. PubMed ID: 17267331 [TBL] [Abstract][Full Text] [Related]
37. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. Cattelan AM; CalabrĂ² ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206 [TBL] [Abstract][Full Text] [Related]
38. Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy. Wilkinson J; Cope A; Gill J; Bourboulia D; Hayes P; Imami N; Kubo T; Marcelin A; Calvez V; Weiss R; Gazzard B; Boshoff C; Gotch F J Virol; 2002 Mar; 76(6):2634-40. PubMed ID: 11861829 [TBL] [Abstract][Full Text] [Related]
39. Detection and sequence analysis of a new herpesvirus-like agent in AIDS and non-AIDS Kaposi's sarcoma in Taiwan. Su IJ; Huang LM; Wu SJ; Jin YT; Kao YF; Tsai TF; Lee JY; Hsu YH; Hsiao CH; Chang YC; Wang YW; Lee CY J Formos Med Assoc; 1996 Jan; 95(1):13-8. PubMed ID: 8640089 [TBL] [Abstract][Full Text] [Related]
40. A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3). Mani D; Neil N; Israel R; Aboulafia DM J Int Assoc Physicians AIDS Care (Chic); 2009; 8(5):279-85. PubMed ID: 19721098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]